Skip to content

The Role of Progesterone Membrane Receptors in the Development of Gestational Diabetes Mellitus

The Role of Progesterone Membrane Receptors in the Development of Gestational Diabetes Mellitus; A Prospective Observational Case-Control Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07750431
Enrollment
90
Registered
2026-08-06
Start date
2026-01-01
Completion date
2027-01-01
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestatiaonl Diabetes Mellitus

Keywords

gestational diabetes mellitus, progesterone membran receptors

Brief summary

The aim of this study is to investigate the potential roles of PGRMC1, PGRMC2, and PAQR family membrane progesterone receptors in the pathophysiology of gestational diabetes mellitus by comparing their expression levels in placentas from pregnancies complicated by gestational diabetes mellitus with those from healthy pregnancies.

Detailed description

Gestational Diabetes Mellitus (GDM) is a medical condition characterized by glycemic intolerance that is detected at any time during pregnancy but was not present prior to it. It can lead to adverse health outcomes. Global data from 2021 indicate that 21.1 million live births involved women (aged 20-49) who experienced some form of diabetes during pregnancy (1). The fundamental mechanism underlying GDM pathophysiology is not yet fully understood; however, it generally results from pancreatic β-cell dysfunction arising from a state of chronic insulin resistance during pregnancy (2). Progesterone is a steroid that plays a central role in maintaining pregnancy; it suppresses uterine contractions and supports fetal immune tolerance (3). Progesterone exerts its effects not only through classical nuclear progesterone receptors but also via membrane-associated progesterone receptors (mPRs). These receptors include PGRMC1, PGRMC2, and the PAQR family (PAQR7, PAQR8, etc.) (4). Paula et al. demonstrated that the elimination of progesterone receptors in β-cells improved β-cell function and glucose tolerance in female mice during pregnancy and diet-induced insulin resistance (5). Furthermore, Picard et al. reported an improvement in glucose homeostasis-driven by β-cell proliferation-in progesterone receptor knockout mice (6). However, data regarding the expression levels of these receptors in the placentas of patients who develop gestational diabetes mellitus remain limited. In light of all this information, the scope of our study is to compare the expression levels of progesterone membrane receptors in placentas from pregnancies complicated by gestational diabetes mellitus and healthy pregnancies, and to determine the roles of these receptors in the pathophysiology of gestational diabetes mellitus.

Interventions

None listed

Sponsors

Samsun University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy women with singleton pregnancies 18-45 years pregnant gestational diabetes mellitus -

Exclusion criteria

Multiple pregnancies pregnant women under the age of 18 or over the age of 45 \-

Design outcomes

Primary

MeasureTime frameDescription
1. Placental PGRMC1,PGRMC2 and PAQR mRNA expression levelsDeliveryRelative placental mRNA expression levels of PGRMC1, PGRMC2 and PAQR family receptors measured by quantitative real-time polymerase chain reaction (qRT-PCR) in placental tissue collected immedia

Countries

Turkey (Türkiye)

Contacts

STUDY_DIRECTORSEMRA EROGLU

Samsun University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026